The Western Cape Government Department of Health (WCG DoH) has issued a tender for the compilation, technical analysis and reporting functionality of a pharmacovigilance monitoring programme for the period of August 2014 to March 2017.
The WCG DoH invited bids from qualified service providers to provide a functioning electronic database for adverse drug reaction (ADR) details. The service provider requires extensive clinical pharmacology experience and must have direct access to Clinical Pharmacologist support.
The successful service provider will be required to submit quarterly reports to Pharmacy Services and the HAST directorate according to WCG DoH specifications, as well as provide feedback to clinicians with respect to additional information that may be required to clarify causality and determine possible preventability strategies.
The tender jointly requests a telephonic medicine information service, which should be provided by a pharmacist or doctor with extensive clinical pharmacology.
Once the standardised ADR database has been developed and implemented, the service provider will be required to support the training of personnel capturing data at a district/hospital level, conduct regular quality assurance audits of data captured and support improvement measures.
Regarding the objectives behind the programme, WCG DoH spokesperson, Mrs Neshaan Peton, stated that “the Department requires a pharmacovigilance/ADR monitoring programme for clinical governance and quality control management of the ARV programme. It gives up an indication of the quality of our services and informs decisions such as types of drugs causing adverse reactions, which can then be substituted.”
The pharmacovigilance programme aims to enhance patient care and patient safety in relation to the use of medicines, and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.
The closing date for applications is April 25th 2014.